All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

24

Reset

24 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • Maridebart cafraglutideAMG 133Phase 314 trials

    Amgen · Obesity, Overweight, Obstructive Sleep Apnea

  • FrexalimabSAR441344Phase 39 trials

    Sanofi · Multiple Sclerosis, Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion

  • MWN109 1Phase 36 trials

    Shanghai Minwei Biotechnology Co., Ltd · Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM)

  • HDM1005 1Phase 34 trials

    Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Type 2 Diabetes, Obesity & Overweight

  • rilparencelRenal Autologous Cell Therapy, REACTPhase 32 trials

    Prokidney · Type 2 Diabetes Mellitus, Chronic Kidney Diseases, Type 1 Diabetes Mellitus

  • THDB0206Phase 32 trials

    Tonghua Dongbao Pharmaceutical Co.,Ltd · Type 2 Diabetes, Type 1 Diabetes

  • TTP399CadisegliatinPhase 32 trials

    vTv Therapeutics · Type 1 Diabetes (T1D), Diabetes Mellitus, Type 1

  • ZimislecelFormerly known as STx-02, VX-880Phase 32 trials

    Vertex Pharmaceuticals · Type 1 Diabetes, Kidney Transplant, Diabetes Mellitus, Type 1

  • ATB-1011Phase 31 trial

    Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2

  • ATB-1012Phase 31 trial

    Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2

  • ATB-1013Phase 31 trial

    Autotelicbio · Essential Hypertension, Diabetes Mellitus, Type 2

  • BR1019A-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019B-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • BR1019C-1Phase 31 trial

    Boryung Pharmaceutical Co., Ltd · Essential Hypertension, Type 2 Diabetes Mellitus

  • VX-017Phase 31 trial

    Vertex Pharmaceuticals · Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia

  • brivekimigSAR442970Phase 25 trials

    Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus

  • BMF-219Phase 22 trials

    Biomea Fusion Inc. · Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus

  • SYH2069group 1, group 2Phase 22 trials

    CSPC Ouyi Pharmaceutical Co., Ltd. · T2DM (Type 2 Diabetes Mellitus), Overweight or Obesity

  • AcmopatideCT-868, RO7795074Phase 21 trial

    Carmot Therapeutics, Inc. · Overweight, Obese, Type 1 Diabetes Mellitus

  • CD25Phase 21 trial

    PolTREG S.A. · Presymptomatic Diabetes Type 1 (Stage 1), Diabetes Mellitus, Type I, Diabetes Mellitus, Type 1

  • CNP-103Phase 21 trial

    COUR Pharmaceutical Development Company, Inc. · Type 1 Diabetes Mellitus, T1D, T1DM

  • SAB-142Phase 21 trial

    SAb Biotherapeutics, Inc. · Type 1 Diabetes

  • VX-264Phase 21 trial

    Vertex Pharmaceuticals · Type 1 Diabetes

  • ZT-01Phase 21 trial

    Zucara Therapeutics Inc. · Type 1 Diabetes Mellitus With Hypoglycemia

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.